Abstract
The identification of biological “markers” indicating distinctively different functions between preneoplastic and neoplastic as compared with normal cells has been a subject of intensive investigation, especially as additional technology becomes available. Although no distinct single biochemical marker is ubiquitous to the process of neoplasia or even to a single histoge- netic type of neoplasm, a variety of histogenetic types of neoplasms in the human and experimental animals exhibit an extreme degree of marker or pheno- typic heterogeneity. Particularly well studied are markers which occurred during the process of hepatocarcinogenesis in the rodent as well as in its final product, the hepatoma. Although phenotypic heterogeneity is characteristic of hepatocellular carcinomas in both the rat and mouse, some degree of predominant marker pattern(s) has become apparent. In multistage hepatocarcinogenesis in the rat a frequent but not completely ubiquitous marker is the enzyme gamma-glutamyltranspeptidase. In the mouse, although such markers have not been as extensively studied as in the rat, glucose 6-phosphatase is a predominant but not exclusive histochemical marker. Many preneoplastic lesions occurring during the stage of promotion exhibit reduced levels of enzymes of oxidative xenobiotic metabolism, but this pattern is not ubiquitous. Studies on the transcription of specific genes in mouse liver as well as preneoplastic and neoplastic lesions in this tissue further demonstrate the phenotypic heterogeneity characteristic of differentiated hepatocellular carcinomas. In general, current evidence supports the two theses that 1) no single biologic marker or set of markers is uniquely characteristic of the preneoplas- tical and/or neoplastic phenotype and 2) marker or phenotypic heterogeneity is by far the rule rather than the exception in hepatocarcinogenesis in the rodent and quite possibly in all histogenetic types of neoplasms in mammals.
Preview
Unable to display preview. Download preview PDF.
References
Armuth V, Berenblum I (1977) Possible two-stage transplacental liver carcinogenesis in C57BL/6 mice. Int J Cancer 20: 292–295
Boveri T (1914) Zur Frage der Entstehung maligner Tumoren. Gustav Fisher, Jena
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically-active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299
Coloma J, Pitot HC (1986) Characterization and sequence of a cDNA clone of gamma-glutamyltranspeptidase. Nuc Acids Res 14: 1393–1403
Custer RP, Sorof S (1984) Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes. Proc Natl Acad Sci USA 81: 6738–6742
Ellis RW, DeFeo D, Maryak JM, Young HA, Shih TY, Chang EH, Lowy DR, Scolnick EM (1980) Dual evolutionary origin for the rat genetic sequences of Harvey Murine Sarcoma Virus. J Virol 36: 408–420
Eriksson L, Ahluwalia M, Spiewak J, Lee G, Sarma DSR, Roomi MJ, Farber E (1983) Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis. Environ Health Persp 49: 171–174
Farber E (1973) Hyperplastic liver nodules. Methods Cancer Res 7: 345–375
Fischer G, Ullrich D, Bock KW (1985) Effects of N-nitrosomorpholine and phenobarbital on UDP-glucuronyltransferase in putative preneoplastic foci of rat liver. Carcinogenesis 6: 605–609
Forrester PI, Hancock RL (1978) Hepatocarcinogen-induced tRNA methylase activity in rat liver. Physiol Chem & Physics 10: 115–123
Friedrich-Freksa H, Papadopulu G, Gössner W (1969) Histochemische Untersuchungen der Cancero- genese in der Rattenleber nach zeitlich begrenzter Verabfolgung von Diäthylnitrosamin. Z Krebsforsch 72: 240–253
Glauert HP, Schwarz M, Pitot HC (1986) The phenotypic stability of altered hepatic foci: effect of the short-term withdrawal of phenobarbital and of the long-term feeding of purified diets after the withdrawal of phenobarbital. Carcinogenesis 7: 117–121
Goldfarb S, Zak FG (1961) Role of injury and hyperplasia in the induction of hepatocellular carcinoma. J Am Med Assoc 178: 729–731
Goldsworthy TL, Pitot HC (1985) The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital. Carcinogenesis 6: 1261–1269
Greenstein JP (1954) Biochemistry of Cancer, 2nd ed. Academic Press, New York
Greenstein JP (1956) Some biochemical characteristics of morphologically separable cancers. Cancer Res 16: 641–647
Hanigan MH, Pitot HC (1985) Gamma-glutamyltranspeptidase - its role in hepatocarcinogenesis. Carcinogenesis 6: 165–172
Kitagawa T, Yokochi T, Sugano H (1972) a-Fetoprotein and hepatocarcinogenesis in rats fed 3-methyl-4-(dimethylamino)azobenzene or N-2-fluorenylacetamide. Int J Cancer 10: 368–381
Kitagawa T, Watanabe R, Sugano H (1980) Induction of gamma-glutamyl transpeptidase activity by dietary phenobarbital in “spontaneous” hepatic tumors of C3H mice. Gann 71: 536–542
Kojima S, Hama Y, Kubodera A (1981) Glucose-6-phosphate dehydrogenase and gamma-glutamyltranspeptidase activities in the liver during chemically induced hepatocarcinogenesis in rats and mice. Toxicol Appl Pharmacol 60: 26–32
Maniatis T, Fritsch EF, Sambrook J (1982) In: Molecular Cloning, A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
Mclntire KR (1984) Tumor markers: how useful are they? Hosp Pract 55–68
Miller EC, Miller JA (1947) The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res 7: 468–475
Moore MR, Pitot HC, Miller EC, Miller JA (1982) Induction of cholangiocellular carcinomas induced in Syrian golden hamsters administered aflatoxin B in large doses. J Natl Cancer Inst 68: 271–278
Naito M, Naito Y, Ito A (1982) Effect of phenobarbital on the development of tumors in mice treated neonatally with N-ethyl-N-nitrosourea. Gann 73: 111–114
Peraino C, Fry RJM, Staffeldt E, Kisieleski WE (1973) Effect of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res 33: 2701–2708
Peraino C, Richards WL, Stevens FJ (1983) Multistage hepatocarcinogenesis. In: Slaga TJ (ed) Mechanisms of Tumor Promoters. Volume 1 - Tumor Promotion in Internal Organs. CRC Press, Inc pp 1–53
Peraino C, Staffeldt EF, Carnes BA, Ludeman VA, Blomquist JA, Vesselinovitch SD (1984) Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res 44: 3340–3347
Pereira MA, Knutsen GL, Herren-Freund SL (1985) Effect of subsequent treatment of chloroform or phenobarbital on the incidence of liver and lung tumors initiated by ethylnitrosourea in 15 day old mice. Carcinogenesis 6: 203–207
Pitot HC (1963) Some biochemical essentials of malignancy. Cancer Res 23: 1474–1482
Pitot HC, Shires TK, Moyer G, Garrett CT (1974) Phenotypic variability as a manifestation of trans- lational control. In: Busch H (ed) The Molecular Biology of Cancer. Academic Press, New York, pp 523–534
Pitot HC, Barsness L, Goldsworthy T, Kitagawa T (1978) Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature 271: 456–458
Potter VR, Watanabe M, Pitot HC, Morris HP (1969) Systematic oscillations in metabolic activity in rat liver and hepatomas. Survey of normal diploid and other hepatoma lines. Cancer Res 29: 55–78
Pugh TD, Goldfarb S (1978) Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res 38: 4450–4457
Rao MS, Lalwani ND, Scarpelli DG, Reddy JK (1982) The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643. Carcinogenesis 3: 1231–1233
Reid E (1962) Significant biochemical effects of hepatocarcinogens in the rat: a review. Cancer Res 22: 398–399
Reynolds RD, Potter VR, Pitot HC, Reuber MD (1971) Survey of some enzyme patterns in transplantable Reuber mouse hepatomas. Cancer Res 31: 808–812
Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K (1985) Purification, induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 82: 3964–3968
Scherer E, Emmelot P (1976) Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis. Cancer Res 36: 2544–2554
Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J (1982) Response of liver foci in rats to hepatic tumor promoters. Toxicol Pathol 10: 63–70
Schulte-Hermann R, Roome N, Timmermann-Trosiener I, Schuppler J (1984) Immunocytochemical demonstration of a phenobarbital-inducible cytochrome P450 in putative preneoplastic foci of rat liver. Carcinogenesis 5: 149–153
Shen-Ong GLC, Keath EJ, Piccoli SP, Cole MD (1982) Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell 31: 443–452
Simickova M, Dolezalova V, Nemecek R (1980) Correlation of deoxycytidylate deaminase activity with cell proliferation during hepatocarcinogenesis and tumour growth in transplantable rat hepatomas. Folia biologica 26: 194–203
Simmons DL, Lalley PA, Kasper CB (1985) Chromosomal assignments of genes coding for components of the mixed-function oxidase system in mice. J Biol Chem 260: 515–521
Sirica AE, Jicinsky JK, Heyer EK (1984) Effect of chronic phenobarbital administration on the gamma-glutamyl transpeptidase activity of hyperplastic liver lesions induced in rats by the Solt/Farber initiation: selection process of hepatocarcinogenesis. Carcinogenesis 5: 1737–1740
Tazawa J, Irie T, French SW (1983) Mallory body formation runs parallel to gamma-glutamyl transferase induction in hepatocytes of griseofulvin-fed mice. Hepatology 6: 989–1001
Warburg O (1930) Metabolism of tumors (translated by F. Dickens). Constable, London Ward JM, Rice JM, Creasia D, Lynch P, Riggs C (1983) Dissimilar patterns of promotion by di(2-eth- ylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis 4: 1021–1029
Ward JM, Rice JM, Creasia D, Lynch P, Riggs C (1983) Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of heparocllular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Cacinogenesis 4:1021-1029
Weber G (1982) Markers of malignancy in cancer cells. Proceedings of the Sixth Meeting of the European Association for Cancer Research, Budapest, 12–15 October 1981, pp 335–345
Williams GM, Ohmori T, Katayama S, Rice JM (1980) Alteration by phenobarbital of membrane-associated enzymes including gamma glutamyl transpeptidase in mouse liver neoplasms. Carcinogenesis 1: 813–818
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag
About this paper
Cite this paper
Beer, D.G., Pitot, H.C. (1987). Biological Markers Characterizing the Development of Preneoplastic and Neoplastic Lesions in Rodent Liver. In: Chambers, P.L., Henschler, D., Oesch, F. (eds) Mouse Liver Tumors. Archives of Toxicology, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71617-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-71617-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-17124-9
Online ISBN: 978-3-642-71617-1
eBook Packages: Springer Book Archive